Brazil

Tue
22
Sep

Paraguay Grows it, Brazil Takes it… Will New Cannabis Laws Change Anything?

South America is becoming a new hotspot for changing cannabis laws, and international cannabis trading. One of the biggest providers of cannabis in South America is Paraguay, with much of its product being moved to Brazil. But it’s all black-market. Can the new rules change this?

Paraguay is a landlocked country in South America which is bordered by Brazil, Argentina, and Bolivia. While it has suffered a significant amount of civil unrest and wars, the country has been democratizing since the late 1900s. This too, has come with years of military instability, political assassinations, and other corruption.

Tue
30
Jun

Marijuana use increased during COVID-19 lockdown, survey shows

The coronavirus pandemic led to a decrease in the use of party drugs like MDMA and cocaine, but also to an increase in pot use, according to Global Drug Survey.

Forty thousand people from 12 countries participated in the online survey that looked at changes in alcohol and drug-related habits during the global health crisis. The 12 countries included in the study were Germany, France, the Netherlands, New Zealand, Ireland, Australia, the United Kingdom, Austria, Denmark, Greece, Brazil, and Switzerland. 

Based on the data, nearly a fifth of people reported that they used less cocaine during lockdown, while 29% said they used less MDMA, popularly known as ecstasy or molly. 

Fri
24
Apr

Brazil Issues Its First Authorization For The Manufacturing Of A Cannabis-Based Product

On Wednesday, Brazil announced in its DOU (Federal Official Gazette), that ANVISA, Brazil's National Health Surveillance Agency,  will allow the manufacturing and marketing of the first cannabis-containing phytopharmaceutical product, with up to 0.2% of THC content.

While ANVISA had approved the creation of a new classification for cannabis products in December, the law only took effect on March 10. And, it was only this Wednesday that the DOU (Federal Official Gazette) disclosed the first manufacturing and marketing permit.

The new proposal speeds up the manufacturing and marketing of cannabis products. Prior to this measure, their import could take a long time, with a high expense for patients.

Tue
24
Dec

Should cannabis be allowed in Brazil to cheapen medicines?

Brazilians will soon be able to buy in drugstores products derived from cannabinoids required by physicians. But, how much will they cost? Will they be affordable for everyone? According to specialists, the answer is no if national cultivation of cannabis is not equally allowed.

Let’s go back to the beginning: the discussions about cannabinoids medicines in Brazil has been long, full of prejudice and conservatism — like unsustained fear of encouraging recreational use, while marijuana is already the most used illicit drug in Brazil, according to Oswaldo Cruz Foundation (Fiocruz).

Thu
12
Dec

New guidelines approved for medical cannabis in Brazil

This week Brazil approved cannabis guidelines in order to establish a legalised environment for the sale and consumption of cannabis for medical use.

Thu
05
Dec

Brazil finally has medical marijuana regulations in place

After several delays, Brazil finally has regulations for launching medical marijuana sales this week.

Brazil’s national health surveillance agency, the Anvisa (Agência Nacional de Vigilância Sanitária), approved regulations for launching medical marijuana sales in the country, with the new rules set to take effect within the next 90 days.

The new regulation allows sales of products with THC levels above 0.2% to terminally-ill patients or those who lack alternative treatment options. Other patients will have access to medical marijuana products with THC levels below 0.2%.

The decision is a small step forward in the country whose right-wing President Jair Bolsonaro is compared to US President Donald Trump.

Wed
04
Dec

Brazil approves medical marijuana rules, blocks cannabis cultivation

Brazilian pharmaceutical regulator Anvisa on Tuesday approved regulations for the roll-out of medicinal cannabis-based products but in a separate vote blocked a proposal to allow domestic medical marijuana plantations.

Anvisa’s approval of rules to regulate the nascent medical marijuana market represents a major shift in a country that has suffered years of deadly drug violence.

Nonetheless, the decision to prohibit domestic plantations shows that Brazil, led by far-right President Jair Bolsonaro, is not yet willing to join peers Colombia and Uruguay and develop its own vertically integrated medical marijuana sector.

A spokesman for Anvisa said that Brazilian firms interested in manufacturing cannabis-based products would need to import inputs from aboard.

Mon
07
Oct

Brazil's medical marijuana market projected to reach US$ 1.1 billion per year

Entrepreneurs continue to invest in Brazil's medical marijuana market, despite a lack of support from Brazil's government. There is no legislation in favor of legalizing medical marijuana in Brazil, and the government disapproved of the National National Health Surveillance Agency's proposal to regulate the issue.

The medical marijuana market is projected to reach R$ 1.1 billion (US$ 269 million) to R$ 4.7 billion (US$ 1.1 billion) per year, according to studies.

The most enthusiastic projection predicts that the country will have at least 3.9 million patients who could be treated with cannabis.

Fri
20
Sep

Why the future marijuana superpower could come from this region

When PharmaCielo, now a publicly traded company, formed in 2014 to cultivate medical cannabis in Colombia, some growers needed convincing. Some came from families that farmed chrysanthemums for generations. Cannabis was largely illegal and stigmatized. Scars from the nation's decadeslong drug war were fresh. A peace deal between the government and leftist FARC rebels was two years away. North America's marijuana stocks boom had not begun.

Thu
04
Jul

Brazil takes next step in creating medical marijuana access for patients in need

Brazil is one of the top medical marijuana importers in the world. British, Canadian, American, and Chinese investors see the country as a place where medical marijuana cultivation and processing will flourish, but only when the government legalizes planting and processing within the country.

That wait may finally be over when this month Anvisa, Brazil’s health agency, publishes two proposals which outline deregulation protocols for cannabis cultivation, research, and medical applications of the drug.

Pages

Subscribe to RSS - Brazil